Treating psychosis involves education, counselling, medication, close monitoring of symptoms, stress management, and a strong, supportive environment.

The Prevention and Early Intervention Program for Psychosis (PEPP-Montréal) is a program for young people who are experiencing an untreated first episode of psychosis.

The Psychotic Disorders Program at the Douglas Institute provides services to adults aged 18 to 65 with schizophrenia or other forms of psychoses, with the exception of the Prevention and Early Intervention Program for Psychoses (PEPP-Montréal), which is designed for people aged 14 to 30.

Ashok Malla is an international leader in the development of programs for, and research in, early intervention in psychosis.

The researchers exploring the “Schizophrenia and neurodevelopmental disorders” theme focus on the causes, course, treatment and prevention of: Schizophrenia and other psychotic disorders Attention deficit hyperactivity disorder (ADHD), conduct disorder, oppositional defiant disorder and Gilles de la Tourette syndrome Autism (research and evaluation) In Canada, one in a hundred people will be diagnosed with schizophrenia while 3 to 5% of children have an attention deficit...

The fourth edition of the Salon de la santé mentale du Sud-Ouest Verdun was highly successful. More than 600 visitors were welcomed to the event at the Centre Champlain.

Prevention and access to care: Priorities for the Douglas

Douglas Institute at the International Conference on Schizophrenia in Chennai, India

Premières observations sur le système de santé mentale en Angleterre

A family view of schizophrenia: Out of the Shadow launches Douglas' movie series